Partner With Dasnovate

ResearchProductPolicy

The Idea

Women’s health is not one isolated concept.It’s a whole ecosystem.

Women’s health data lives across conditions, body systems, technologies, behaviors, environments, and every stage of life.

But seeing the whole picture means more than bringing the data together. It means asking whether the measures themselves fit the women we are trying to understand.

Cardiovascular Health Metabolic Health Chronic Disease Reproductive Health Fertility Menopause Healthy Aging Behavioral Health Digital Health Healthcare Access Population Health Lived Experience Social Determinants Health Economics Cardiovascular Health Metabolic Health Chronic Disease Reproductive Health Fertility Menopause Healthy Aging Behavioral Health Digital Health Healthcare Access Population Health Lived Experience Social Determinants Health Economics

A biomarker, threshold, endpoint, or algorithm may not mean the same thing across every population or every stage of a woman’s life.

Are we measuring women accurately in the first place?

So, isn’t it about time?

The Dasnovate Model

One Mission. Three Connected Arms.

The Dasnovate model, powered by DASHA DASHA, Dasnovate Health Analytics, sits at the centre as the evidence engine and connects outward to three arms — Research, Products and Policy — which in turn sit on a ring and feed one another in a continuous cycle. DASHA Dasnovate Health Analytics The evidence engine 01 Research Generate the evidence 02 Products Build better tools 03 Policy Turn evidence into action

Research brings women’s data out of silos. Products build from it. Policy uses it to change systems. Each arm sharpens the next.

Research

We generate rigorous women’s health evidence by asking better questions of existing and real-world data — connecting what is fragmented, testing what may not fit, and identifying what is missing.

Break women’s data out of silos. Find what isn’t working.

Products

We turn what we learn into analytical concepts and tools for health tech, wearables, algorithms, biomarkers, and data solutions — built around women from the start.

Build from women’s evidence — not retrofit women later.

Policy

We translate women’s health evidence into decision-ready insight — using population health, affordability, and policy analysis to address the systems shaping health outcomes.

Use women’s evidence to break down systemic barriers.

Working on a question that spans research, product, or policy?

Partner With Dasnovate

The Work

Arm 01 · Research

Featured Research

Why this matters

Heart disease remains the leading cause of death among women.

So how do we get better at identifying cardiovascular risk in women?

We need better ways to measure risk — including biomarkers, measurable biological clues such as substances found in blood — and thresholds for interpreting them that are validated specifically in women.

But even among women, those measures may not mean the same thing across every reproductive life stage.

That is where our question begins.

The question

A blood test already used to understand iron status may hold information about cardiovascular health that we have not fully explored.

Ferritin is a biomarker used to assess the body’s iron stores. Using existing data from the Women’s Health Initiative, we asked whether this familiar and relatively accessible biomarker might also tell us something about cardiovascular health among women in postmenopause.

A laboratory blood tube labelled Ferritin, showing separated serum above red cells.

What we observed

Among older postmenopausal women, lower ferritin was associated with a greater chance of heart attack, stroke, heart failure, and related cardiovascular events.

But the relationship was not a straight line.

Why reproductive stage matters

A biomarker may not carry the same meaning across reproductive life stages.

Women are not one uniform population.

Five illustrated portraits along a timeline representing the reproductive life stages, deepening in colour from left to right.
Premenstrual Menstruation Reproductive Years Perimenopause PostmenopauseOur study examined this stage.

What this signal tells us

This was a proof of concept using data that already existed. No new data collection or study-specific funding was required. The analysis does not provide a definitive answer; it identifies a direction worth investigating more deeply.

The finding is not the finish line. It tells us where it may be worth looking next.

Where we should invest next

Ferritin is already measurable, relatively accessible, and inexpensive. Findings like this can help identify which existing biomarkers and questions deserve deeper validation and research investment.

Accessible Practical Testable

Sometimes innovation means getting creative with what we already have.

Research Status

This is observational research. It does not establish causation, and the findings require replication and further validation.

  1. Presented

    AHA EPI|Lifestyle Scientific Sessions 2026

  2. Published Abstract

    Circulation abstract supplement →

  3. In Peer Review

    Full manuscript under peer review.

Have a biomarker, dataset, or endpoint that may not mean the same thing for women?

Discuss a Project

Arm 02 · Products

What We’re Building

Dasnovate is developing a portfolio of analytical concepts designed for the realities of women’s health data. These concepts are at different stages of development.

The platform

DASHA

Dasnovate Health Analytics

The evidence engine — the architecture under which Dasnovate’s analytical tools are developed, connected, and expanded over time.

Analytical concepts within DASHA

CLARA

Active development

An analytical concept for identifying clinically meaningful patterns, heterogeneity, phenotypes, and potential bias within women’s health data.

SANDHYA

Early research

A synthetic-data concept for generating more representative data structures and populations — for analytical development, validation, and testing.

Additional analytical tools can be developed within the DASHA ecosystem as the platform evolves.

What if women’s health tools were built from women’s evidence from the start — not retrofitted later?

Arm 03 · Policy

Policy & Public-Interest Work

Independent, quantitative, nonpartisan analysis of the conditions shaping women’s health — built for decision-makers and the public alike.

Flagship research initiative

The Cost to Health of NYC Women

A Dasnovate research initiative examining the health burden associated with the lived experiences and economic realities of modern women in New York City.

Follow the report →

Independently conceived, funded, and conducted by Dasnovate using publicly available data. Not affiliated with, endorsed by, or produced on behalf of any government agency, employer, or institution.

Dr. Shabitri B. Dasgupta, founder of Dasnovate

About the Founder

Dr. Shabitri B. Dasgupta, DrPH, MPH, RCIS

Women’s Health ScientistCardiovascular EpidemiologistChief Executive Officer

My Why

Entrepreneurship wasn’t the original plan. I’m a scientist first.

While I was getting my master’s in public health, I serendipitously found myself in one of the busiest cardiac catheterization labs in the country at Mount Sinai Hospital in New York City. There, I was exposed to cardiovascular disease at its most serious and saw firsthand what happens when heart disease reaches the point of intervention. Somewhere along the way, I fell in love with cardiology.

But I also kept noticing things that bothered me — especially how often the frameworks we used to understand cardiovascular disease did not seem to fit women particularly well.

Epidemiology became my way of asking bigger questions. It allowed me to take what I was seeing one patient at a time and examine it across populations. My doctoral research eventually brought those worlds together through the Women’s Health Initiative, where I learned both the rigor of studying women’s health at scale and the value of translating evidence into questions that matter in the real world.

But the more research I encountered, the more one question stayed with me:

How does that evidence become a better tool, a better product, a better decision — something that actually changes what happens for women?

Then AI took off, and the stakes became even clearer. If women are missing from the evidence, they can be missed by the technologies built from it too — at scale.

Women cannot be an afterthought in what gets built next.

That became the vision: better health innovation for women.

Not simply more research. Not innovation for innovation’s sake. But taking better evidence beyond the paper and using it to shape the products, tools, and decisions that ultimately reach women.

One night, while working on my dissertation, it clicked:

Oh. I have to do it.

Suddenly, a path that had once felt nonlinear made sense. The bedside, the data, the research, the population, the tools — each had taught me to see a different part of the same problem.

Maybe I hadn’t been directionless at all.

Dasnovate is where those pieces come together — and how I’m working toward better health innovation for women.

The Throughline

It was never as fragmented as it looked.

Dasnovate Vision Clinical CardiologyThe patient EpidemiologyThe patterns Women’s HealthResearchThe evidence Public HealthThe scale Data ScienceThe tools

Each experience gave me a different lens

that shaped my approach.

Together, they brought the Dasnovate vision into focus.

Evidence Behind the Work

Dasnovate brings together scientific rigor, clinical insight, public health expertise, and data science.

Women’s Health Research

Research using Women’s Health Initiative data examining ferritin and cardiovascular health among postmenopausal women.

Epidemiology & Public Health

Expertise in epidemiologic study design, public health research, survey methods, statistical analysis, and evidence translation.

Cardiovascular Science

Clinical cardiovascular experience combined with cardiovascular epidemiology and research.

Partner With Dasnovate

Bring a women’s health lens to the questions that matter.

Dasnovate partners with organizations that need rigorous women’s health expertise across research, data, and scientific strategy.

We work with health-tech companies, researchers, universities, startups, foundations, healthcare organizations, and other groups working in women’s health.

Currently accepting project and collaboration inquiries.

Research & Evidence

Study design, evidence generation, validation, and synthesis across women’s health.

  • Epidemiologic study design
  • Real-world evidence
  • Outcomes research
  • Validation research
  • Survey & population research
  • Evidence synthesis

Data & Analytics

Statistical, epidemiologic, and population-health analysis built around the scientific question.

  • Statistical analysis
  • Epidemiologic analysis
  • Population health analysis
  • Measurement & validity assessment
  • Data interpretation & synthesis

Strategy & Translation

Taking evidence into products, policy, strategy, reports, editorial work, and communication.

  • Scientific strategy & advisory
  • Evidence-to-product translation
  • Research roadmaps & evidence gaps
  • Policy & decision-maker translation
  • Reports, briefs & editorial storytelling
  • Scientific & public-facing communication

Different outputs. Same rigor.

A study.An analysis.A validation strategy. A policy brief.An evidence report.An editorial story.

Whatever the output, Dasnovate brings the same women’s health lens, epidemiologic rigor, clinical context, population thinking, and data-driven approach.

Support Dasnovate

Support the work behind better evidence for women’s health.

If the mission resonates, you can shop Dasnovate. Your support helps us build women’s health research, analytical tools, and public-interest work.

Shop Dasnovate

Wear the mission. Help us keep building it.

Your purchase helps support the research, tools, and ideas Dasnovate is building for women’s health.

Browse the shop

Dasnovate Women’s Health Analytics LLC is an independent private company. Purchases and direct support are not charitable contributions and are not tax deductible.

Publishing

Research & Insights

Original analyses, data stories, scientific commentary, and policy briefs on women’s health. Dasnovate is being built as a destination for substantive women’s health analytics.